chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the male patient, approximately the age of one (1) years old did not show any signs or symptoms; Medical Assistant called to ask if there are any issues or problems if PROQUAD and VARIVAX were administered to a 1 year old at the same time and date; This spontaneous report was received from a medical assistant referring to a male patient of approximately 1-year-old. The patient's concurrent conditions, medical history, concomitant medications, and drug reactions/allergies were not reported.  On 10-AUG-2020, the patient was vaccinated with 0.5 mL varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneously (lot # T002844, expiration date 23-JAN-2022) and with 0.5 mL measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) subcutaneously ((lot # S031705, expiration date 06-APR-2021) as vaccination. The reporter called to ask if there was any issue or problems if both vaccines were administered at the same time and date. It was stated the patient did not show any signs or symptoms for excessive vaccine administration.
I am currently out of town for my grandson's graduation, and I was about to leave to go back home. I had to end up going to the urgent care for severe cough and congestion. I was seen by the doctor and had medication to take. I went back yesterday due to symptoms not getting better at all. I saw the Dr., he prescribed amoxicillin and nausea medication. I was also seen by another Dr. the second time I went back. I also had a COVID test as well yesterday and I am waiting on the results. All my other dose were Moderna. I still have the rash on my scalp that I previously reported.
Mother noted blood in infant's stool one day after immunizations were given.  Infant was fussy the evening of vaccines, but has been fine since.
Pt. in intermittent sun for 2-3 hours on 4/7/03.Sunburn across checks and nose and sclera edema of Right eye noted.  Pt. normally wouldn't sunburn that easily, and denies any seasonal allergies to account for Right eye problem.Cheeks and eyes very puffy on 4/8/03.
This case was reported by a consumer and described the occurrence of taste altered in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced taste altered. On an unknown date, the outcome of the taste altered was unknown. It was unknown if the reporter considered the taste altered to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Food or drinks taste bad day after SHINGRIX shot. The patient wanted to know was this side effect of SHINGRIX.
Within the hour of getting the vaccine my throat and lungs began feeling constricted and congested. I feel like i am in a constant asthma attack that advair and albuterol will not help. It has been weeks since the first injection and it has not gotten any better, it hasn't gotten worse either. I have not sought medical attention due to the rise in cases, what i am feeling does seem severe enough to go in, but i feel is directly related.
lockjaw/tetanus;pt recv vax 25JUL96 & 8AUG96 exp lockjaw;tx @ hosp;also exp face swelling;
Patient sent to the ED with bilateral pneumonia.  Patient admitted to hospital with Covid and treated with remdesivir.
Patient s/p vaccination in spring 2021. Admitted to the hospital on 8/9/2021 with generalized weakness. Pt reported chronic dry cough, malaise and runny nose; denied chest pain, SOA, V/N/D. No known exposures to COVID. Patient found to be COVID+; started on oxygen, dexamethasone and remdesivir. O2 requirements continued to worsen; imaging showed worsening PNA - concern for secondary aspiration PNA. Started on IV zosyn. After 10 days with worsening confusion, agitation patient family decided to transition to comfort measures. Pt agreed to Hospice on 8/19 and passed on 8/20
Patient received Smallpox vaccination.  6/5/04. Started noticing left eye itching, swelling.  Went to ER.  6/12/04.  Today feels like sand in eye.  Only using one RX now.  Dx: Ocular vaccinia left upper lid.
This spontaneous report concerning a 57 year old male patient, was received from the patient himself. His concurrent conditions included high blood pressure. However, he had no drug reactions/allergies and his medical history was not reported. On an unknown date (reported as "over two years ago"), the patient was vaccinated with ZOSTAVAX (dose, dosage number, route of administration, anatomical location, lot # and expiration date were not reported). His concomitant medications included an unspecified medication. Subsequently, in approximately 2014 (reported as "about two years ago"), the patient started to experience hives and about a year ago, in approximately 2015, the patient experienced muscle aches. A routine blood work had been performed but the results were not provided. The patient sought medical attention from various physicians and received an unspecified treatment. However, at the time of reporting, the events of hives and muscle aches had not resolved. Additionally, no product quality complaint was involved and the patient failed to provide a causal relationship between the events and the vaccination with ZOSTAVAX. Additional information has been requested.
Arm soreness; This is a spontaneous report from a contactable Other HCP (patient). A 43-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL1283) intramuscular in left arm on 19Jan2021 at 09:00 (at the age of 43-year-old) as single dose for COVID-19 immunization at Doctor's office/urgent care. Medical history of the patient included depression and anxiety. Concomitant/other medications received within two weeks included lamotrigine (LAMICTAL), fluoxetine hydrochloride (PROZAC), monascus purpureus (RED YEAST RICE), curcuma longa (TURMERIC), boswellia serrata (BOSWELLIA), acacia catechu wood, chondroitin sulfate sodium, glucosamine hydrochloride, hyaluronic acid, maltodextrin, methylsulfonylmethane, scutellaria baicalensis root (GLUCOSAMINE CHONDROITIN), VITAMIN D3, CHROMIUM PICOLINATE all taken for unspecified indications. No other vaccine was received within four weeks of suspect vaccine. Patient had no known allergies. Patient did not have COVID prior vaccination and was not tested for Covid post vaccination. On an unspecified date in 2021 after the first dose, patient experienced arm soreness and nothing else. Patient did not receive any treatment in response to the event. Outcome of the event was resolving.  Follow-up attempts completed. No further information expected.
experiencing upper leg pain (flu); This is a spontaneous report from a contactable consumer (patient) from a Pfizer Sponsored Program. A female patient of unknown age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unknown route of administration on 29Jan2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 on an unknown date. The patient experienced upper leg pain (flu) on an unknown date. The clinical outcome of the event upper leg pain was unknown.   The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.
FELT LIKE HIT BY A MACK TRUCK; CHILLS; COULD NOT GET WARM; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the patient experienced felt like hit by a mack truck. On APR-2021, the patient experienced chills. On APR-2021, the patient experienced could not get warm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt like hit by a mack truck, chills, and could not get warm. This report was non-serious.
Information has been received from a physician concerning a child who on unspecified dates had received 2 doses of MMR II vaccine (doses, duration and lot numbers were not reported). The physician reported that he had done some laboratory work to confirm the diagnosis of mumps. He indicated that he did not find the child to be immunoglobulin M (IgM) positive for mumps, but was immunoglobulin G (IgG) positive. The physician said the child had a four fold rise in mumps antibody titer. It was noted that the child had parotid gland swelling. At the time of the report, the patient's status was unknown. This is one of several reports received from the same source. Additional information has been requested.
Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, Moderna #1 03/10 Pfizer, Moderna #2 0825 pt cc: cough, fever, headache, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown clinically resolved 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing result: pending
102 degree temperature; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Jul2021 at 15:00 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient previously took pertussis vaccine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other medications within two weeks of vaccination. On an unknown date in Jul2021 the patient received meningitis b vaccine (MANUFACTURER UNKNOWN). On an unknown date in Jul2021 the patient experienced 102 degree temperature and vomiting. On an unknown date in Jul2021 patient underwent test which include body temperature and the result was 102 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 102 degree temperature and vomiting were unknown.    The lot number for BNT162b2 was not provided and will be requested during follow up.
Received 3 doses Hepatitis B vaccine (brand known) & was nonresponder.
Breakthrough case admission after 3 vaccines  Moderna 2/9/21 Lot# 031L20A;  Moderna 3/9/21 Lot# 032M20A;  Moderna 10/27/21 Lot# 076C21A
pt recv vax 15OCT96 & 22OCT96 devel redness w/burnt-like skin, bruising, skin eruptions & a burning sensation on feet;tx by dermatologist w/cream & ointments w/o improvement;sx d/t allergic rxn to flu;redness w/burn sensation spread to hand
After pt received her vaccine she was initially OK, she sat down in a chair while her brother received his Immunization. Upon standing up to leave the exam room she had a syncope event in which she hit her head on the handle of the door. The MA witnessed the event and immediately call for assistance. 911 was activated and Multiple staff responded. Pt slowly regained consciousness. Pt was wearing glasses at the time of the event and the glasses were broken with the earpiece embedded in the skin at the  lateral aspect of the right eyebrow. Bleeding was controlled with pressure. Once the EMT's arrived the wound and the  embedded glass earpiece were covered and wrapped to maintain control. Pt was alert at time she left on the squad, pt was taken to clinic for treatment of the wound and head injury.
Discomfort in the axillary zone of the arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Discomfort in the axillary zone of the arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Discomfort in the axillary zone of the arm). At the time of the report, LIMB DISCOMFORT (Discomfort in the axillary zone of the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were unknown. Treatment details were not provided.
3 office personnel recvd the flu shot in October & in December came down w/type a flu;
Patient started having some low-grade chills and aches around 3/2/21.  Her first COVID-19 vaccine was received on 3/1/21, so she was originally attributing these symptoms to the vaccine.  She has had some diarrhea.  Mild headache, muscle aches.  However, she started to develop some dyspnea on exertion and mild cough that is nonproductive.  When she realized her sister was having symptoms of COVID and tested positive and she had had some mild exposures to her, she realizes she might have active COVID infection and was tested positivity on 3/6.  She has had poor appetite and poor oral intake compared to average.  On 3/12, she became weak, fatigued, having diarrhea, and a difficult time urinating, advised to ED by PCP. So, patient was admitted for COVID-19 pneumonitis on 3/12. Received dexamethasone 3/12 to 3/21.  Discharged home on 3/19/21 with supplemental oxygen.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old male patient received BNT162b2 (BNT162B2), on 30Mar2022 as dose number unknown, single (Lot number: 4122) at the age of 72 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 11Sep2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) positive, notes: Treatment of COVID-19; (11Sep2022) positive, notes: Positive test day 6 after last Paxlovid course. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Follow-up attempts are completed. No further information is expected.
fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Feb2021 14:00 (Lot number: EN6200, Expiration Date: Feb2022) at the age of 73 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (ongoing), notes: diagnosed with diabetes 12 years ago; "MS" (ongoing), notes: diagnosed about 45 years ago . The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 17Feb2021, outcome "recovered" (Feb2021), described as "fatigue". Therapeutic measures were taken as a result of fatigue.  Additional information: The fatigue resolved after a couple of days. It was reported that the patient was taking acetaminophen aspirin caffeine since day 1 (18Feb2021).  No follow-up attempts are possible. No further information is expected.
A medical assistant administer a influenza vaccine to patient on 12/01/2020. Patient is only 2 months and does not qualify to get influenza until 6 months of age. Provider checked patient after the administration of the vaccine and stated to medical assistant that the patient was ok and she did not have any immediate reaction to the vaccine. I will be following up with the mother of the patient on 12/02/2020.
if she can take Ibuprofen to ease the pain for her injury; if she can take Ibuprofen to ease the pain for her injury; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021305533 (Pfizer).  A female patient received bnt162b2 (BNT162B2), administration date 13Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), INJURY (non-serious), outcome "unknown" and all described as "if she can take Ibuprofen to ease the pain for her injury". Therapeutic measures were taken as a result of pain (Tylenol (14Mar2021)).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information: 2nd dose of bnt162b2 was scheduled on 03Apr2021.
Red swollen fevered arm.  Started approximately 2 or 3 in the morning.  Same symptoms 18 hours later.
Received Expired Dose of Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.  Patients were administered vaccine from the vials which exceeded the 30 day refrigeration limit.The vials were placed in the refrigerator on 21-Apr-2021and stayed in the same location until their administration date on 25-May-2021
8/20/02 at approx 4:30 to say infant had behaved "strange" following his immunizations. The day before, received DTaP and Prevnar said infant had trembling-cried a lot and stated after that afternoon said infant did not behave "normal" a few hours after shots at time of call said infant was okay now but was concerned about behavior.
Difficulty breathing, wheezing, paleness, weakness swelling where the shot was given, cold chills. Epipen, BENADRYL, XOPENEX, oxygen at office. Transported via ambulance to ER.
Kinrix instead of a regular Dtap vaccine; 17 months received Kinrix; was 4th dose of DTaP; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 17-month-old female patient who received DTPa-IPV (Kinrix) (batch number 2KL4K, expiry date 9th November 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 5th December 2022, the patient received the 4th dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 5th December 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered, inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the wrong vaccine administered, inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 06-DEC-2022 Reporter's Comments: Nurse reported that a 17 months female child received by error Kinrix instead of a regular Dtap vaccine.  This would be a fourth IPV portion on patient´s schedule.  Kinrix was the patients 4th dose of DTaP as well. The reporter consented to follow up via email. Additional Supportive Information: The 17 month patient was administered with kinrix instead of regular Dtap, which led to inappropriate age at vaccine administration and wrong vaccine administered and inappropriate schedule of vaccine administered.
Dizziness, Headache, NauseaVomiting, loss of appetite, stuffy nose, eyes drainage Narrative:
Fatigue after the first and second Moderna Covid-19 vaccines in the prmary series.  vaccine; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (Fatigue after the first and second Moderna Covid-19 vaccines in the prmary series.  vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue after the first and second Moderna Covid-19 vaccines in the prmary series.  vaccine). At the time of the report, FATIGUE (Fatigue after the first and second Moderna Covid-19 vaccines in the prmary series.  vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment was reported   This case was linked to MOD-2022-580294, MOD-2022-580295 (Patient Link).   Reporter did not allow further contact
Patient states rashes appeared starting from the back of the legs and traveled to ankles, arms, hands, and back. Patient did not seek medical attention. The rashes were itchy.
Swelling, redness, "heavy feeling" that night. Measured at clinic 06/09 11x11cm, red, hot, swollen below injection site. Dx: cellulitis. Rx Augmentin 875mg BID x 5 days.
Appx 24 hours after the injection, the site of injection started itching very badly and a bright red solid spot appeared and a lump that was sore to touch.  Redness was just smaller than a quarter at first. That was about 5:10pm 3/5 and then  appx 8-9 hours later, while sleeping, I developed a severe cough and my nose was completely stopped up. Eyes were itching with drainage too. My husband got up and gave me a Benadryl and that calmed everything down so I could sleep again.  This morning, my eyes were pretty red and still had some drainage. My cough is there but very faint and less frequent. My arm hasn?t stopped itching and the red spot is slightly larger at appx 1.5 inches tall and 1 inch wide. Still with a lump and soreness. I expected the lump and soreness.
Patient reported feeling dizzy. Patient was sitting in chair and fainted approximately 5 minutes after receiving the vaccine. Patient was unresponsive for about 30 seconds. Patient was not injured from fainting (This writer was able to catch him and guide him to the ground). Patient remained in pharmacy for about 45 minutes. Patient was given water, a cold compress, and candy (Patient felt that his blood sugar was low and requested candy). Patient left feeling well.